Shaun Chilton
Director/Board Member bij AVACTA GROUP PLC
Oorsprong van het eerstegraads netwerk van Shaun Chilton
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Miscellaneous Commercial Services | 29 | |
| Public Company | Miscellaneous Commercial Services | 11 | |
Clinigen SP Ltd.
 Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Shaun Chilton via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| VECTURA GROUP | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| ABCAM PLC | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Chairman Director of Finance/CFO | |
| The University of Manchester | College/University | Doctorate Degree Undergraduate Degree | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Trinity College Dublin | College/University | Undergraduate Degree Graduate Degree | |
| University of Birmingham | College/University | Undergraduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
Penn Pharmaceutical Services Ltd.
 Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Penn Pharmaceutical Services Ltd. provides drug development, clinical trial supply and pharmaceutical manufacturing services. Its services include solid oral and topical products formulation, pilot batches scale up and testing, clinical trials supplies manufacturing, process validation and technology transfer, formulation and analytical development, clinical trial packing and labeling, and storage and distribution. The company was founded in 1977 and is headquartered in Tredegar, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Idis Ltd.
 Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Henley Management College | College/University | Masters Business Admin Masters Business Admin | |
| Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Biotechnology | Director/Board Member | |
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Macrotarg Ltd.
 Macrotarg Ltd. BiotechnologyHealth Technology Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK. | Biotechnology | Director/Board Member Director/Board Member | |
| Alan Boyd Consultants Ltd. | Chief Executive Officer | ||
Mitre Group Ltd.
 Mitre Group Ltd. Miscellaneous Commercial ServicesCommercial Services Mitre Group Ltd. provides sports and stadia training services. The firm consults on providing apprenticeships, staff development courses and pre-employment programmes. It offers coach education, sports development, youth work, stadia safety, management and leadership, customer service, employability skills, health and safety and first aid. The company is headquartered in Derby, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| REDCENTRIC PLC | Information Technology Services | Chairman Director/Board Member | |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| NIOX GROUP PLC | Medical/Nursing Services | Chairman Director/Board Member | |
| ERGOMED | Miscellaneous Commercial Services | Director/Board Member Chairman | |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
Clinigen CTS Ltd.
 Clinigen CTS Ltd. Medical DistributorsDistribution Services Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The private company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship. | Medical Distributors | Director/Board Member Director/Board Member | |
Clinigen Healthcare Ltd.
 Clinigen Healthcare Ltd. Medical DistributorsDistribution Services Part of Triley Bidco Ltd., Clinigen Healthcare Ltd. is a British company founded in 2007 that has more than 30 years of experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The private company is based in Burton-on-Trent, UK. The company's investigator-initiated studies services provide smart solutions to investigators, with managed regulatory pathways required for support of IIS & EAP programs. Through the Clinigen Management Access, patient and healthcare professionals are granted access to the medicines they need. | Medical Distributors | Director/Board Member Director/Board Member | |
Keats Healthcare Ltd.
 Keats Healthcare Ltd. Keats Healthcare Ltd. engages in manufacturing and processing of drugs in pharmaceutical preparations for human or veterinary use. The company was founded on May 15, 2008 and is headquartered in Burton-On-Trent, the United Kingdom. | Director/Board Member Director/Board Member | ||
| QUANTUM PHARMA PLC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Wichtig Publishing SRL | Director/Board Member Director/Board Member | ||
| MedCity Ltd. | Chairman | ||
Linear Diagnostics Ltd.
 Linear Diagnostics Ltd. Medical SpecialtiesHealth Technology Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom. | Medical Specialties | Director/Board Member | |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Creabilis SA | Chief Executive Officer | ||
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chairman | |
| Wichtig International Ltd. | Chairman Director/Board Member | ||
| F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Spinifex Pty Ltd. | Director/Board Member | ||
| Atlantic Pharmaceuticals (Holdings) Ltd. | Director/Board Member | ||
Triley Bidco Ltd.
 Triley Bidco Ltd. Financial ConglomeratesFinance Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| Liverpool Health Partners Ltd. | Chairman |
Statistieken
Internationaal
| Verenigd Koninkrijk | 42 |
| Verenigde Staten | 4 |
| Ierland | 3 |
| Italië | 3 |
| Luxemburg | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 205 |
| Corporate Officer/Principal | 72 |
| Chairman | 61 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 40 |
Sterkste connecties
| Insiders | |
|---|---|
| Eliot Forster | 35 |
| Elmar Schnee | 31 |
| Peter George Lutz | 31 |
| Ian Johnson | 30 |
| Peter Allen | 26 |
| Trevor Nicholls | 19 |
| Christian Rigg | 19 |
| Ian James Nicholson | 19 |
| Tony Gardiner | 17 |
| Mark Goldberg | 17 |
| Sharon Curran | 14 |
| Anne Philomena Hyland | 13 |
| Paul Fry | 12 |
| Alan Keith Boyd | 12 |
| Matthew Charles Turner | 11 |
- Beurs
- Insiders
- Shaun Chilton
- Bedrijfsconnecties
